BackMeridian Bioscience Overview

Meridian Bioscience Cost of Revenue

Cost of Revenue analysis for VIVO.

Quarterly Cost of Revenue

$25.40M
↓ 35.18% YoY

As of Dec 31, 2022

Annual Cost of Revenue (TTM)

$130.88M
↑ 5.07% YoY

Trailing 12 months ending Dec 31, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin